PMID- 12962413 OWN - NLM STAT- MEDLINE DCOM- 20031009 LR - 20230315 IS - 1344-4964 (Print) IS - 1344-4964 (Linking) VI - 51 IP - 8 DP - 2003 Aug TI - Left ventricular mass index reduction early after an isolated aortic valve replacement with St. Jude Medical 19A-HP. PG - 361-7 AB - OBJECTIVES: It has been reported that the left ventricular mass index (LVMI) for the hypertrophic myocardium is reduced at an early stage following surgery. In this study, those factors affecting the changes in early postoperative LVMI were investigated in cases in which a St. Jude Medical 19A-HP (19HP) mechanical heart valve was used. METHODS: We studied 16 consecutive patients with pure aortic stenosis undergoing isolated aortic valve replacement using a 19HP between January 1994 and July 2001. The patients were all female, aged 64 +/- 6 years, with a body surface area of 1.44 +/- 0.10 m2 and preoperative New York Heart Association (NYHA) classification of 2.2 +/- 0.5. All patients underwent transthoracic echocardiography at 4.2 +/- 3.3 days before and 16.3 +/- 10.2 days after operation, and cardiac catheterization within a mean period of one month before operation. The correlations between the decrease of LVMI at 16.3 +/- 10.2 days after operation and perioperative parameters were determined. RESULTS: There was significant LVMI regression postoperatively (15 +/- 12%, p = 0.01), and only a significant negative correlation between the decrease of LVMI and preoperative left ventricular pressure (LVp) [r = -0.74, p < 0.01]. There was no effective LVMI reduction in the high preoperative LVp group (> or = 210 mmHg). CONCLUSION: It is expected that in the high LVp group, huge wall stress was being applied to the left ventricular muscle immediately before surgery and in the early period after surgery. Preoperative LVp is an important index for determining the surgical timing and safe perioperative management. We recommend early surgical treatment before LVp becomes more than 210 mmHg. FAU - Uchikawa, Shin AU - Uchikawa S AD - Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan. FAU - Aomi, Shigeyuki AU - Aomi S FAU - Kawai, Akihiko AU - Kawai A FAU - Yamazaki, Kenji AU - Yamazaki K FAU - Tomizawa, Yasuko AU - Tomizawa Y FAU - Nishida, Hiroshi AU - Nishida H FAU - Endo, Masahiro AU - Endo M FAU - Koyanagi, Hitoshi AU - Koyanagi H LA - eng PT - Comparative Study PT - Evaluation Study PT - Journal Article PL - Japan TA - Jpn J Thorac Cardiovasc Surg JT - The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi JID - 100884261 RN - 0 (Bretschneider cardioplegic solution) RN - 0 (Insulin) RN - 0 (glucose-insulin-potassium cardioplegic solution) RN - 3OWL53L36A (Mannitol) RN - 4Z8Y51M438 (Procaine) RN - 660YQ98I10 (Potassium Chloride) RN - IY9XDZ35W2 (Glucose) RN - RWP5GA015D (Potassium) SB - IM MH - Aged MH - Aortic Valve/physiopathology/*surgery MH - Female MH - Glucose/therapeutic use MH - Heart Valve Diseases/physiopathology/*surgery MH - Heart Valve Prosthesis Implantation/*instrumentation MH - Heart Ventricles/physiopathology/surgery MH - Humans MH - Insulin/therapeutic use MH - Japan MH - Mannitol/therapeutic use MH - Middle Aged MH - Potassium/therapeutic use MH - Potassium Chloride/therapeutic use MH - Procaine/therapeutic use MH - Prosthesis Design MH - Retrospective Studies MH - Statistics as Topic MH - Stroke Volume/physiology MH - Time Factors MH - Treatment Outcome MH - Ventricular Pressure/physiology EDAT- 2003/09/10 05:00 MHDA- 2003/10/10 05:00 CRDT- 2003/09/10 05:00 PHST- 2003/09/10 05:00 [pubmed] PHST- 2003/10/10 05:00 [medline] PHST- 2003/09/10 05:00 [entrez] AID - 10.1007/BF02719468 [doi] PST - ppublish SO - Jpn J Thorac Cardiovasc Surg. 2003 Aug;51(8):361-7. doi: 10.1007/BF02719468.